ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement

ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best NASDAQ stocks under $30 to buy. On March 2, ADMA Biologics announced a significant capital return initiative for 2026, targeting a total of ~$200 million in share repurchases. As a primary component of this plan, the company entered into a $125 million ASR (accelerated share repurchase) agreement with JPMorgan Chase Bank. This move is supported by the company’s strong financial standing and sustained free cash flow.

Under the specific terms of the ASR, ADMA Biologics will provide an upfront payment of $125 million to JPMorgan and expects to initially receive ~6.4 million shares on or about March 3. This initial delivery represents ~80% of the anticipated total repurchases based on recent closing prices. The average volume-weighted price will determine the final number of shares during the term of the agreement, which is projected to conclude within the next five months.

This initiative is part of a broader $500 million repurchase program authorized in May 2025, through which the company has already returned ~$160 million to stockholders. Moving forward, ADMA Biologics Inc. (NASDAQ:ADMA) intends to remain opportunistic, potentially using Rule 10b5-1 trading plans or open-market transactions to meet the remainder of its 2026 goals.

ADMA Biologics Inc. (NASDAQ:ADMA) is a biotech company that develops and markets specialty plasma-derived biologics for immune deficiencies and infectious diseases through the ADMA BioManufacturing and Plasma Collection Centers segments.

While we acknowledge the risk and potential of ADMA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ADMA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None.  Follow Insider Monkey on Google News.